Literature DB >> 12664009

Hemangiomas of infancy.

Anna L Bruckner1, Ilona J Frieden.   

Abstract

UNLABELLED: Hemangiomas of infancy are unique, benign, pediatric tumors of endothelial cells characterized by an initial phase of rapid proliferation, followed by slow involution, often leading to complete regression. Although most of these tumors are small and innocuous, some may be may be life- or function-threatening, or have associated structural congenital anomalies. Uncertainties regarding their diagnosis or management often prompt referral to a dermatologist. The pathogenesis of hemangiomas of infancy is not well understood, but recent findings suggest a unique vascular phenotype with dysregulated vascular homeostasis. This article reviews new information regarding the pathogenesis of these tumors and highlights the more worrisome presentations, including syndromic hemangiomas, that are likely to be problematic. In addition, management strategies and treatment options are discussed. (J Am Acad Dermatol 2003;48:477-93.) LEARNING
OBJECTIVE: At the completion of this learning activity, participants should be able to describe the clinical features of hemangiomas of infancy and potential complications as well as to understand the strengths and limitations of various treatment options.

Entities:  

Mesh:

Year:  2003        PMID: 12664009     DOI: 10.1067/mjd.2003.200

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  41 in total

Review 1.  Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence.

Authors:  T M Ranchod; I J Frieden; D R Fredrick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 2.  Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-08-26       Impact factor: 3.183

3.  Huge, alarming congenital hemangioma of the scalp presenting as heart failure and Kasabach-Merritt syndrome: a case report.

Authors:  Cheng-Hui Hsiao; Po-Nien Tsao; Wu-Shiun Hsieh; Hung-Chieh Chou
Journal:  Eur J Pediatr       Date:  2006-08-26       Impact factor: 3.183

4.  Microvascular proliferation in congenital vascular malformations of skin and soft tissue.

Authors:  Lorine B Meijer-Jorna; Chris M van der Loos; Onno J de Boer; Chantal M A M van der Horst; Allard C van der Wal
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

5.  Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.

Authors:  Preeti Tiwari; Vaibhav Pandey; Ajay N Gangopadhyay; Shiv P Sharma; Dinesh K Gupta
Journal:  Oral Maxillofac Surg       Date:  2015-10-20

Review 6.  Educational paper: therapy of infantile haemangioma--history and current state (part II).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-09-03       Impact factor: 3.183

7.  Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod.

Authors:  Anne Marie Tremaine; Jennifer Armstrong; Yu-Chih Huang; Leila Elkeeb; Arisa Ortiz; Ronald Harris; Bernard Choi; Kristen M Kelly
Journal:  J Am Acad Dermatol       Date:  2012-01-14       Impact factor: 11.527

Review 8.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

9.  Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo.

Authors:  Ning Wang; Hongxia Chen; Yinping Teng; Xionghui Ding; Huan Wu; Xianqing Jin
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

Review 10.  The changing face of complicated infantile hemangioma treatment.

Authors:  Deanna Menapace; Mario Mitkov; Richard Towbin; Marcia Hogeling
Journal:  Pediatr Radiol       Date:  2016-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.